Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1316-1324

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Jong, S. C.
Right arrow Articles by Rauwerda, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Jong, S. C.
Right arrow Articles by Rauwerda, J. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-METHIONINE
*CYANOCOBALAMIN
*FOLIC ACID
*PYRIDOXINE HYDROCHLORIDE
Related Collections
Right arrow Risk Factors
Right arrow Genetics of cardiovascular disease
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1316-1324.)
© 1999 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Determinants of Fasting and Post-Methionine Homocysteine Levels in Families Predisposed to Hyperhomocysteinemia and Premature Vascular Disease

S. C. de Jong; C. D. A. Stehouwer; M. van den Berg; P. J. Kostense; D. Alders; C. Jakobs; G. Pals; J. A. Rauwerda

From the Institute for Cardiovascular Research (S.C.d.J., C.D.A.S., M.v.d.B., D.A., C.J., J.A.R.); Department of Surgery, Division of Vascular Surgery, Academisch Ziekenhuis (S.C.d.J., M.v.d.B., J.A.R.); Department of Internal Medicine, Academisch Ziekenhuis (C.D.A.S.); Department of Epidemiology and Biostatistics, and Institute for Research in Extramural Medicine (P.J.K.); Department of Clinical Chemistry, Academisch Ziekenhuis (C.J.); Department of Anthropogenetics (G.P.), Vrije Universiteit, Amsterdam, The Netherlands.

Correspondence to Dr C.D.A. Stehouwer, Department of Internal Medicine, Academisch Ziekenhuis Vrije Universiteit, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. E-mail cda.stehouwer{at}azvu.nl

Abstract—Elevated plasma total homocysteine (tHcy) levels, either measured in the fasting state or after oral methionine loading, are associated with an increased risk of atherothrombotic disease. Fasting and post-methionine hyperhomocysteinemia (HHC) overlap to a limited extent; both can occur as familial traits. We investigated determinants of fasting, postmethionine and delta (ie, post-methionine minus fasting levels) tHcy levels in 510 subjects of 192 HHC-prone families including 161 patients with clinical vascular disease and 349 without vascular disease. We focused on tHcy levels in relation to levels of vitamin B12, B6 and folate and the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Multivariate linear analyses adjusted for the presence of vascular disease showed that fasting tHcy was significantly related to folate and vitamin B12, and the presence of the MTHFR TT genotype and the T allele, and to age, smoking habits, and serum levels of creatinine. Both post-methionine and delta tHcy levels were related to serum folate levels, and the presence of the MTHFR TT genotype and the T allele, and to postmenopausal status, and body mass index. An interaction was found between MTHFR TT genotype and serum folate levels for both fasting and post-methionine tHcy, ie, for a given decrease in serum folate, homocysteine levels increased more in subjects with the TT genotype than in those with the CC genotype. Fasting, post-methionine and delta tHcy were higher in patients with vascular disease than in their healthy siblings, but these levels were less dependent on serum folate levels (P<0.05), whereas the effect of MTHFR genotype was stronger (P=0.01). This study found evidence that post-methionine and delta tHcy levels are not only influenced by factors affecting homocysteine transsulfuration but also by factors that affect remethylation. The explained variances of fasting, post-methionine and delta tHcy were 49%, 62%, and 78%, respectively. We also found evidence, in patients with premature vascular disease but not in their healthy siblings, for a factor that increases tHcy levels but weakens the normal inverse relation between folate and tHcy and amplifies the effect of the MTHFR genotype.


Key Words: homocysteine • methionine loading test • methylenetetrahydrofolate reductase • vitamins • familial hyperhomocysteinemia • premature vascular disease




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. I. Holm, P. M. Ueland, S. E. Vollset, O. Midttun, H. J. Blom, M. B.A.J. Keijzer, and M. den Heijer
Betaine and Folate Status as Cooperative Determinants of Plasma Homocysteine in Humans
Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 379 - 385.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. L. Sacco, K. Anand, H.-S. Lee, B. Boden-Albala, S. Stabler, R. Allen, and M. C. Paik
Homocysteine and the Risk of Ischemic Stroke in a Triethnic Cohort: The Northern Manhattan Study
Stroke, October 1, 2004; 35(10): 2263 - 2269.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. I. Holm, O. Bleie, P. M. Ueland, E. A. Lien, H. Refsum, J. E. Nordrehaug, and O. Nygard
Betaine as a Determinant of Postmethionine Load Total Plasma Homocysteine Before and After B-Vitamin Supplementation
Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 301 - 307.
[Abstract] [Full Text]


Home page
Vasc MedHome page
R. van der Griend, D. H Biesma, and J.-D. Banga
Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens
Vascular Medicine, February 1, 2002; 7(1): 29 - 33.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. G. J. Vermeulen, H. W. M. Niessen, M. Bogels, C. D. A. Stehouwer, J. A. Rauwerda, and V. W. M. van Hinsbergh
Decreased Smooth Muscle Cell/Extracellular Matrix Ratio of Media of Femoral Artery in Patients With Atherosclerosis and Hyperhomocysteinemia
Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 573 - 577.
[Abstract] [Full Text] [PDF]